To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis
Clinical trial NCT06147518 · UNKNOWN
Trial details
- NCT number
- NCT06147518
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2024-12-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.